BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19764563)

  • 1. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
    Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
    Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
    Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.
    Tang JM; He QY; Guo RX; Chang XJ
    Lung Cancer; 2006 Feb; 51(2):181-91. PubMed ID: 16324768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.
    Ma Y; Zhang P; Gao Y; Fan H; Zhang M; Wu J
    Int J Clin Exp Pathol; 2015; 8(11):14875-84. PubMed ID: 26823817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
    Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
    Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.
    Ke TW; Wei PL; Yeh KT; Chen WT; Cheng YW
    Ann Surg Oncol; 2015 Aug; 22(8):2649-55. PubMed ID: 25515201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change from inflammation to carcinoma in ulcerative colitis: the role of PTEN/PI3K/AKT].
    Fu DG; Huang XL; Gan HT; Zhang DK; Zhao LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1021-3, 1052. PubMed ID: 20067111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
    Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PI3K, PTEN and Akt in small intestinal adenocarcinoma detected by quantum dots-based immunofluorescence technology.
    Zhang Y; Yao X; Jiang C; Yue J; Guan J; Cheng H; Hajirashid M; Wang Y; Fan L
    Cancer Biomark; 2013; 13(4):299-305. PubMed ID: 24240591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.
    Al-Saad S; Donnem T; Al-Shibli K; Persson M; Bremnes RM; Busund LT
    Anticancer Res; 2009 Oct; 29(10):4175-83. PubMed ID: 19846969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
    Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
    Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.